07:49 AM EDT, 08/12/2026 (MT Newswires) -- Arbutus Biopharma ( ABUS ) reported a Q2 loss Wednesday of $0.03 per diluted share, swinging from earnings of $0.01 a year earlier.

One analyst surveyed by FactSet expected a loss of $0.02.

Revenue for the quarter ended June 30 was $1 million, compared with $10.7 million a year earlier.

One analyst surveyed by FactSet expected $700,000.

Shares of the company were down 3.9% pre-bell.